The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singaporean Health Sciences Authority (HSA) say the ...

RNA interference drug developer SanegeneBio leads our round-up of this week's biotech financings, with a $110 million Series ...

Drug delivery is no longer just about convenience. It’s about enabling the therapies of the future to succeed where they ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

Pfizer's oral HER2 inhibitor Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive ...

This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...

Chambers discusses her personal experience as a GP in the NHS, including the discrimination she faced as a woman, and ...

In September, Takeda announced that it is making pharma history – becoming the first in the industry to ship medicines across ...

Today, the EU Council and Parliament reached an agreement in principle on the long-awaited pharma reform package, but ...